The round was led by Insurtech Gateway, with participation from U-Investors, Tenity, and a group of angel investors.
Founded in 2023, Klaimy leverages artificial intelligence to extract medical conditions from documents with a reported accuracy rate of over 98%. Its platform is built to address major industry pain points such as fraud detection, missing data, and clinical inconsistencies—critical challenges in both underwriting and claims handling.
The company’s roadmap extends beyond extraction technology. Klaimy is developing AI-driven tools designed to support insurer decision-making, aiming to offer solutions that not only automate but intelligently assist.
The fresh capital will be used to expand Klaimy’s engineering and data science teams, enhance product capabilities, and fast-track its commercial rollout across Europe.
“We’re solving a core pain point that every health and life insurer faces: how to make fast, accurate decisions on complex medical files,” said Amira Nakouri, CEO of Klaimy. “Our mission is to turn medical data chaos into clarity—with AI that doesn’t just automate, but truly assists.”
Richard Chattock, CEO of lead investor Insurtech Gateway, praised Klaimy’s founding team and vision: “They bring an exceptional mix of AI expertise and insurance know-how. Their platform is not only simplifying workflows but significantly improving accuracy and decision-making. We’re excited to back their journey.”
Klaimy joins a growing list of European insurtechs using AI to modernize legacy processes and drive operational efficiency across the insurance value chain.
